Rekombinanter BRD7 Antikörper (AA 150-200)
-
- Target Alle BRD7 Antikörper anzeigen
- BRD7 (Bromodomain Containing 7 (BRD7))
- Antikörpertyp
- Recombinant Antibody
-
Bindungsspezifität
- AA 150-200
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser BRD7 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Flow Cytometry (FACS)
- Verwendungszweck
- Rabbit anti-BRD7 Recombinant Monoclonal Antibody [BLR220K]
- Immunogen
- between AA 150 and 200
- Klon
- BLR220K
- Isotyp
- IgG
- Top Product
- Discover our top product BRD7 Primärantikörper
-
-
- Applikationshinweise
- 01:01,00
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 500 μg/mL
- Buffer
- Borate Buffered Saline (BBS) pH 8.2 with 0.1 % BSA and 0.09 % Sodium Azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Haltbarkeit
- 12 months
-
- Target
- BRD7 (Bromodomain Containing 7 (BRD7))
- Andere Bezeichnung
- BRD7 (BRD7 Produkte)
- Hintergrund
- Background: Bromodomain-containing protein 7 was identified in a two-hybrid screen as an interactor of interferon regulatory factor-2 (IRF-2) and called CELTIX1. BRD7 was also identified as a binding partner of disheveled-1 (Dvl-1) and found to play a role in Wnt signaling and the regulation of glycogen synthase kinase 3-beta activity. Recently, BRD7 was identified as a subunit of the polybromo-associated BRG1-associated factor (PBAF) complex and shown to be required for the modulation of transcription in embryonic stem cells.
- Gen-ID
- 29117
- NCBI Accession
- NP_037395
- UniProt
- Q9NPI1
-